FilingIndex
10-QThe Record

Keros Therapeutics, Inc. files 10-Q

Filed May 5, 2022 · 4y ago · Accession 0001664710-22-000019

Plain English

Quarterly report — three-month financials and management discussion.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
KROS
CIK
1664710
Form type
10-Q
Filing date
May 5, 2022
Report date
Mar 31, 2022
Document
kros-20220331.htm
Size
3.5 MB